Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer
AbstractProstate cancer is considered the second most common visceral malignancy in men in Western countries. Its emergence is largely due to the coordination of a malignant network, and long noncoding RNA has been recently demonstrated to play a critical role in prostate carcinogenesis. The aberrant expression of long noncoding RNA in prostate cancer patients is strongly associated with diagnosis, risk stratification and carcinogenesis, information that provides new insight into the complicated intracellular milieu of prostate cancer. This review focuses mainly on literature evidence for the role of long noncoding RNA in prostate cancer, which may suggest novel strategies for its prognosis, diagnosis and clinical treatment. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Su, Y.-J.; Yu, J.; Huang, Y.-Q.; Yang, J. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer. Int. J. Mol. Sci. 2015, 16, 13322-13338.
Su Y-J, Yu J, Huang Y-Q, Yang J. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer. International Journal of Molecular Sciences. 2015; 16(6):13322-13338.Chicago/Turabian Style
Su, Yin-Jie; Yu, Jin; Huang, Ya-Qin; Yang, Jin. 2015. "Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer." Int. J. Mol. Sci. 16, no. 6: 13322-13338.